시장보고서

상품코드

1526401

Drug Discovery 인포매틱스 시장 - 규모, 점유율, 동향, 산업 분석 보고서 : 용도별, 모드별, 서비스별, 최종 사용자별, 지역별 시장 예측(2024-2032년)

Global Drug Discovery Informatics Market Size, Share, Trends, Industry Analysis Report: By Application, By Mode, By Services, By End-User, and By Region - Market Forecast, 2024 - 2032

발행일: 2024년 07월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 118 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris market research의 최근 조사에 따르면, 세계의 의약품 정보 시장 규모는 2032년까지 81억 3,256만 달러에 달할 전망입니다. 이 보고서는 현재 시장 역학을 상세하게 통찰하고 미래 시장 성장에 대한 분석을 제공합니다.

인공지능과의 통합과 클라우드 컴퓨팅과 같은 기술적 진보는 창약 정보 시장의 성장을 가속하고 있습니다. 기술을 기반으로 한 여러 기업이 건강 관리 산업의 급증하는 요구를 충족시키기 위해 신약 솔루션을 도입했습니다. 헬스케어에서 AI의 응용은 의약 과정에 혁명을 일으켜 복잡한 생의학 데이터의 취급을 더욱 능숙하게 만듭니다. 따라서 혁신적인 기술 업그레이드는 창약 정보 시장의 성장을 뒷받침하고 있습니다.

게다가, 신약 프로세스를 가속화하기 위해 기업이 수행하는 많은 투자는 시장 성장을 뒷받침하고 있습니다. 이러한 투자는 Drug Discovery 인포매틱스의 능력을 강화하고 혁신적인 치료법에 대한 길을 열고 있습니다. 그 결과, 첨단 인포매틱스 모델과 엄청난 자금 지원의 조합이 의약품 개발을 촉진하고 Drug Discovery 인포매틱스 시장의 성장을 가속하고 있습니다.

업계 기업의 확대·성장 활동도, Drug Discovery 인포매틱스의 발전을 뒷받침하고 있습니다. 이러한 활동에는 연구기관, 학술기관, 제약회사와의 인수, 제휴, 파트너십 등이 포함되어 시장의 혁신을 촉진하고 있습니다. 게다가, 의약품 정보 시장은 경쟁이 치열하여 여러 세계 기업과 지역 기업들이 시장의 패권을 다투고 있습니다. 세계 기업은 AI 주도 통찰력, 데이터 분석, 제약 연구에 특화된 클라우드 기반 솔루션 등 혁신적인 제품을 제공하여 시장을 독점하고 있습니다.

신약 정보학 시장 보고서 하이라이트

제약기업에 의한 연구개발활동의 활성화로 시장의 신약개발 부문은 향후 수년간 대폭적인 성장이 예상됩니다.

2023년에는 BLAST, FASTA, CLUSTALW와 같은 첨단 플랫폼이 최신 의약품 및 약물 개발을 크게 촉진했기 때문에 시퀀싱 분석 플랫폼 부문이 수익 측면에서 시장을 독점했습니다. 이러한 플랫폼을 통해 연구자들은 방대한 양의 유전체 데이터를 효율적으로 분석하고 해석할 수 있게 되었습니다.

북미 Drug Discovery 인포매틱스 시장은 견조한 제약 업계의 존재로 인해 가장 큰 판매 점유율을 차지합니다.

세계의 Drug Discovery 인포매틱스 기업이 창약과 개발의 주요 기업로서 중국에 대한 관심을 높이고 있다는 것은 중국의 Drug Discovery 인포매틱스 시장의 성장을 가속할 것으로 예상됩니다.

세계 주요 시장 기업은 Accenture, Agilent Technologies, Inc., Boehringer Ingelheim International GmbH, Certara, Charles River Laboratories, Chemaxon Ltd., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Illumina, Inc., Infosys Limited, Jubilant Biosys Ltd., Oracle, QIAGEN, Sapio Sciences, Selvita입니다.

용도 스냅샷
Drug Discovery 인포매틱스 시장 역학
- 성장 촉진요인과 기회
  - 업계 기업이 채용하고 있는 중요한 성장 전략이, Drug Discovery 인포매틱스 시장의 성장을 견인
  - 희소질환용 제품 개발을 위한 정부의 대처가 Drug Discovery 인포매틱스 시장 규모 확대를 견인
- 억제요인과 과제
  - 데이터 품질의 일관성의 결여가 Drug Discovery 인포매틱스의 도입을 방해하고 있다
PESTEL 분석
Drug Discovery 인포매틱스 시장의 응용 동향
밸류체인 분석
COVID-19의 영향 분석

제5장 세계의 Drug Discovery 인포매틱스 시장 : 용도별

주요 조사 결과
소개
신약개발
의약품 개발

제6장 세계의 Drug Discovery 인포매틱스 시장 : 모드별

주요 조사 결과
소개
아웃소싱
인하우스

제7장 세계의 Drug Discovery 인포매틱스 시장 : 서비스별

주요 조사 결과
소개
임상시험 데이터 관리
도킹
분자 모델링
시퀀싱 분석 플랫폼
기타

제8장 세계의 Drug Discovery 인포매틱스 시장 : 최종 사용자별

주요 조사 결과
소개
바이오테크놀러지 기업
CRO
제약기업
기타

제9장 세계의 Drug Discovery 인포매틱스 시장 : 지역별

주요 조사 결과
소개
- Drug Discovery 인포매틱스 시장 평가:지역별, 2019-2032년
북미
- 미국
- 캐나다
유럽
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
라틴아메리카
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제10장 경쟁 구도

확대와 인수 분석
- 확대
- 인수
제휴/협업/합의/공개

제11장 기업 프로파일

Accenture
Agilent Technologies, Inc.
Boehringer Ingelheim International GmbH
Certara
Charles River Laboratories
Chemaxon Ltd.
Collaborative Drug Discovery Inc.
Eurofins DiscoverX Products
Illumina, Inc.
Infosys Limited
Jubilant Biosys Ltd.
Oracle
QIAGEN
Sapio Sciences
Selvita

JHS 24.08.22

The global drug discovery informatics market size is expected to reach USD 8,132.56 million by 2032, according to a new study by Polaris Market Research. The report "Global Drug Discovery Informatics Market Size, Share, Trends, Industry Analysis Report: Information By Application (Drug Discovery, Drug Development), By Mode, By Services, By End-User, and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Technological advancements such as integration with artificial intelligence and cloud computing are propelling the growth of the drug discovery informatics market. Several technology-based companies are introducing drug discovery solutions to meet the burgeoning needs of the healthcare industry. The application of AI in healthcare is revolutionizing the drug discovery process, making it more adept at handling the complexity of biomedical data. Therefore, innovative technological upgrades are propelling the growth of the drug discovery informatics market.

Moreover, the substantial investments made by companies to accelerate drug discovery processes are also fueling market growth. These investments have bolstered the capabilities of drug discovery informatics, paving the way for innovative therapeutics. Consequently, the combination of advanced informatics models with substantial financial backing is fostering drug development, thus stimulating the growth of the drug discovery informatics market.

The expansion and growth activities of industry players also fuel the development of drug discovery informatics. The activities include acquisitions, collaborations, and partnerships with research organizations, academic institutions, and pharmaceutical companies to drive innovation in the market. Moreover, the drug discovery informatics market is competitive, with several global and regional players vying for market dominance. Global players are dominating the market with innovative offerings that cover AI-driven insights, data analytics, and cloud-based solutions tailored specifically for pharmaceutical research.

Drug Discovery Informatics Market Report Highlights

The market's drug development segment is expected to experience substantial growth in the coming years due to the rising research and development activities by pharmaceutical companies.

In 2023, the sequence analysis platforms segment dominated the market in terms of revenue because advanced platforms such as BLAST, FASTA, and CLUSTALW significantly facilitated modern drug discovery and development. These platforms empowered researchers to analyze and interpret vast amounts of genomic data efficiently.

The North American drug discovery informatics market held the largest revenue share due to the presence of a robust pharmaceutical industry.

The growing interest of global drug discovery informatics companies in China as a key player in drug discovery and development is expected to drive the growth in the China drug discovery informatics market.

The global key market players are Accenture, Agilent Technologies, Inc., Boehringer Ingelheim International GmbH, Certara, Charles River Laboratories, Chemaxon Ltd., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Illumina, Inc., Infosys Limited, Jubilant Biosys Ltd., Oracle, QIAGEN, Sapio Sciences, and Selvita.

Polaris Market Research has segmented the drug discovery informatics market report based on application, mode, services, end-user, and region:

Drug Discovery Informatics, Application Outlook (Revenue - USD Million, 2019 - 2032)

Drug Discovery
Identification, Validation, & Assay Development Informatics
Lead Generation
Drug Development
FHD Preparation
Lead Optimization
Phase IA
Phase IB/2

Drug Discovery Informatics, Mode Outlook (Revenue - USD Million, 2019 - 2032)

Outsourced
In-house

Drug Discovery Informatics, Services Outlook (Revenue - USD Million, 2019 - 2032)

Clinical Trial Data Management
Docking
Molecular Modeling
Sequence Analysis Platforms
Others

Drug Discovery Informatics, End User Outlook (Revenue - USD Million, 2019 - 2032)

Biotechnology Companies
Contract Research Organization (CROs)
Pharmaceutical Companies
Others

Drug Discovery Informatics, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of APAC
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of MEA

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Drug Discovery Informatics Market Insights

4.1. Drug Discovery Informatics Market - Application Snapshot
4.2. Drug Discovery Informatics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Significant growth strategies employed by industry players are driving the drug discovery informatics market growth
  - 4.2.1.2. Government initiatives for developing products for rare diseases are propelling the drug discovery informatics market size
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Inconsistent data quality is hindering the adoption of drug discovery informatics
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Drug Discovery Informatics Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Drug Discovery Informatics Market, by Application

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
5.3. Drug Discovery
- 5.3.1. Global Drug Discovery Informatics Market, by Drug Discovery, by Region, 2019-2032 (USD Million)
- 5.3.2. Identification, Validation, & Assay Development Informatics
  - 5.3.2.1. Global Drug Discovery Informatics Market, by Identification, Validation, & Assay Development Informatics, by Region, 2019-2032 (USD Million)
- 5.3.3. Lead Generation
  - 5.3.3.1. Global Drug Discovery Informatics Market, by Lead Generation, by Region, 2019-2032 (USD Million)
5.4. Drug Development
- 5.4.1. Global Drug Discovery Informatics Market, by Drug Development, by Region, 2019-2032 (USD Million)
- 5.4.2. FHD Preparation
  - 5.4.2.1. Global Drug Discovery Informatics Market, by FHD Preparation, by Region, 2019-2032 (USD Million)
- 5.4.3. Lead Optimization
  - 5.4.3.1. Global Drug Discovery Informatics Market, by Lead Optimization, by Region, 2019-2032 (USD Million)
- 5.4.4. Phase IA
  - 5.4.4.1. Global Drug Discovery Informatics Market, by Phase IA, by Region, 2019-2032 (USD Million)
- 5.4.5. Phase IB/2
  - 5.4.5.1. Global Drug Discovery Informatics Market, by Phase IB/2, by Region, 2019-2032 (USD Million)

6. Global Drug Discovery Informatics Market, by Mode

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
6.3. Outsourced
- 6.3.1. Global Drug Discovery Informatics Market, by Outsourced, by Region, 2019-2032 (USD Million)
6.4. In-house
- 6.4.1. Global Drug Discovery Informatics Market, by In-house, by Region, 2019-2032 (USD Million)

7. Global Drug Discovery Informatics Market, by Services

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
7.3. Clinical Trial Data Management
- 7.3.1. Global Drug Discovery Informatics Market, by Clinical Trial Data Management, by Region, 2019-2032 (USD Million)
7.4. Docking
- 7.4.1. Global Drug Discovery Informatics Market, by Docking, by Region, 2019-2032 (USD Million)
7.5. Molecular Modeling
- 7.5.1. Global Drug Discovery Informatics Market, by Molecular Modeling, by Region, 2019-2032 (USD Million)
7.6. Sequence Analysis Platforms
- 7.6.1. Global Drug Discovery Informatics Market, by Sequence Analysis Platforms, by Region, 2019-2032 (USD Million)
7.7. Others
- 7.7.1. Global Drug Discovery Informatics Market, by Others, by Region, 2019-2032 (USD Million)

8. Global Drug Discovery Informatics Market, by End User

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
8.3. Biotechnology Companies
- 8.3.1. Global Drug Discovery Informatics Market, by Biotechnology Companies, by Region, 2019-2032 (USD Million)
8.4. Contract Research Organization (CROs)
- 8.4.1. Global Drug Discovery Informatics Market, by Contract Research Organization (CROs), by Region, 2019-2032 (USD Million)
8.5. Pharmaceutical Companies
- 8.5.1. Global Drug Discovery Informatics Market, by Pharmaceutical Companies, by Region, 2019-2032 (USD Million)
8.6. Others
- 8.6.1. Global Drug Discovery Informatics Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Drug Discovery Informatics Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Drug Discovery Informatics Market Assessment, By Geography, 2019-2032 (USD Million)
9.3. Drug Discovery Informatics Market - North America
- 9.3.1. North America: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
- 9.3.2. North America: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
- 9.3.3. North America: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
- 9.3.4. North America: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.3.5. Drug Discovery Informatics Market - U.S.
  - 9.3.5.1. U.S.: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.3.5.2. U.S.: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.3.5.3. U.S.: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.3.5.4. U.S.: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.3.6. Drug Discovery Informatics Market - Canada
  - 9.3.6.1. Canada: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.3.6.2. Canada: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.3.6.3. Canada: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.3.6.4. Canada: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
9.4. Drug Discovery Informatics Market - Europe
- 9.4.1. Europe: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
- 9.4.2. Europe: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
- 9.4.3. Europe: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
- 9.4.4. Europe: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.4.5. Drug Discovery Informatics Market - UK
  - 9.4.5.1. UK: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.4.5.2. UK: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.4.5.3. UK: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.4.5.4. UK: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.4.6. Drug Discovery Informatics Market - France
  - 9.4.6.1. France: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.4.6.2. France: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.4.6.3. France: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.4.6.4. France: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.4.7. Drug Discovery Informatics Market - Germany
  - 9.4.7.1. Germany: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.4.7.2. Germany: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.4.7.3. Germany: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.4.7.4. Germany: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.4.8. Drug Discovery Informatics Market - Italy
  - 9.4.8.1. Italy: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.4.8.2. Italy: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.4.8.3. Italy: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.4.8.4. Italy: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.4.9. Drug Discovery Informatics Market - Spain
  - 9.4.9.1. Spain: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.4.9.2. Spain: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.4.9.3. Spain: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.4.9.4. Spain: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.4.10. Drug Discovery Informatics Market - Netherlands
  - 9.4.10.1. Netherlands: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.4.10.2. Netherlands: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.4.10.3. Netherlands: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.4.10.4. Netherlands: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.4.11. Drug Discovery Informatics Market - Russia
  - 9.4.11.1. Russia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.4.11.2. Russia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.4.11.3. Russia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.4.11.4. Russia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.4.12. Drug Discovery Informatics Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.4.12.2. Rest of Europe: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.4.12.3. Rest of Europe: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.4.12.4. Rest of Europe: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
9.5. Drug Discovery Informatics Market - Asia Pacific
- 9.5.1. Asia Pacific: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
- 9.5.2. Asia Pacific: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
- 9.5.3. Asia Pacific: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
- 9.5.4. Asia Pacific: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.5.5. Drug Discovery Informatics Market - China
  - 9.5.5.1. China: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.5.5.2. China: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.5.5.3. China: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.5.5.4. China: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.5.6. Drug Discovery Informatics Market - India
  - 9.5.6.1. India: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.5.6.2. India: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.5.6.3. India: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.5.6.4. India: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.5.7. Drug Discovery Informatics Market - Malaysia
  - 9.5.7.1. Malaysia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.5.7.2. Malaysia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.5.7.3. Malaysia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.5.7.4. Malaysia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.5.8. Drug Discovery Informatics Market - Japan
  - 9.5.8.1. Japan: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.5.8.2. Japan: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.5.8.3. Japan: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.5.8.4. Japan: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.5.9. Drug Discovery Informatics Market - Indonesia
  - 9.5.9.1. Indonesia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.5.9.2. Indonesia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.5.9.3. Indonesia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.5.9.4. Indonesia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.5.10. Drug Discovery Informatics Market - South Korea
  - 9.5.10.1. South Korea: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.5.10.2. South Korea: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.5.10.3. South Korea: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.5.10.4. South Korea: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.5.11. Drug Discovery Informatics Market - Australia
  - 9.5.11.1. Australia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.5.11.2. Australia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.5.11.3. Australia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.5.11.4. Australia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.5.12. Drug Discovery Informatics Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.5.12.2. Rest of Asia Pacific: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.5.12.3. Rest of Asia Pacific: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.5.12.4. Rest of Asia Pacific: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
9.6. Drug Discovery Informatics Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
- 9.6.2. Middle East & Africa: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
- 9.6.3. Middle East & Africa: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
- 9.6.4. Middle East & Africa: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.6.5. Drug Discovery Informatics Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.6.5.2. Saudi Arabia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.6.5.3. Saudi Arabia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.6.5.4. Saudi Arabia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.6.6. Drug Discovery Informatics Market - UAE
  - 9.6.6.1. UAE: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.6.6.2. UAE: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.6.6.3. UAE: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.6.6.4. UAE: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.6.7. Drug Discovery Informatics Market - Israel
  - 9.6.7.1. Israel: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.6.7.2. Israel: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.6.7.3. Israel: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.6.7.4. Israel: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.6.8. Drug Discovery Informatics Market - South Africa
  - 9.6.8.1. South Africa: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.6.8.2. South Africa: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.6.8.3. South Africa: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.6.8.4. South Africa: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.6.9. Drug Discovery Informatics Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.6.9.2. Rest of Middle East & Africa: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.6.9.3. Rest of Middle East & Africa: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.6.9.4. Rest of Middle East & Africa: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
9.7. Drug Discovery Informatics Market - Latin America
- 9.7.1. Latin America: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
- 9.7.2. Latin America: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
- 9.7.3. Latin America: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
- 9.7.4. Latin America: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.7.5. Drug Discovery Informatics Market - Mexico
  - 9.7.5.1. Mexico: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.7.5.2. Mexico: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.7.5.3. Mexico: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.7.5.4. Mexico: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.7.6. Drug Discovery Informatics Market - Brazil
  - 9.7.6.1. Brazil: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.7.6.2. Brazil: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.7.6.3. Brazil: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.7.6.4. Brazil: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.7.7. Drug Discovery Informatics Market - Argentina
  - 9.7.7.1. Argentina: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.7.7.2. Argentina: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.7.7.3. Argentina: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.7.7.4. Argentina: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
- 9.7.8. Drug Discovery Informatics Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  - 9.7.8.2. Rest of Latin America: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  - 9.7.8.3. Rest of Latin America: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  - 9.7.8.4. Rest of Latin America: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Accenture
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Agilent Technologies, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Boehringer Ingelheim International GmbH
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Certara
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Charles River Laboratories
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Chemaxon Ltd.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Collaborative Drug Discovery Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Eurofins DiscoverX Products
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Illumina, Inc.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Infosys Limited
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Jubilant Biosys Ltd.
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Oracle
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. QIAGEN
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Sapio Sciences
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
11.15. Selvita
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development